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Thoracic endovascular aneurysm repair, race, and
volume in thoracic aneurysm repair
Philip P. Goodney, MD, MS,a,b Benjamin S. Brooke, MD, PhD,a Jessica Wallaert, MD, MS,a
Lori Travis, MS,c F. Lee Lucas, PhD,c David C. Goodman, MD, MS,b Jack L. Cronenwett, MD,a and
David H. Stone, MD,a Lebanon and Hanover, NH; and Portland, Me
Background: Volume-based disparities in surgical care are often associated with poorer results in African American
patients. We examined the effect of treatment patterns and outcomes, by race, for isolated thoracic aortic aneurysm
(TAA).
Methods: Using Medicare claims (1999-2007), we studied all patients undergoing repair of TAAs, via open surgery or
thoracic endovascular aneurysm repair (TEVAR). We studied 30-day mortality and complications by race, procedure
type, and hospital volume.
Results: We studied 12,573 patients who underwent open TAA repair (4% of whom were black) and 2732 patients who
underwent TEVAR (8% of whom were black). In open repair, black patients had higher 30-day mortality than white
patients (18% vs 10%; P < .001), while mortality rates were similar with TEVAR (8% black vs 9% white; P  .56). For
open repair, black patients weremore likely to undergo surgery at low-volume hospitals, where overall operativemortality
was highest (14% at very low-volume hospitals, 7% at very high-volume hospitals; P< .001). However, for TEVAR, black
patients were not more likely to undergo repair at low-volume hospitals, andmortality differences were not evident across
volume strata (9% at very low-volume hospitals, 7% at very high-volume hospitals; P  .328). Multivariable analyses
adjusting for age, sex, race, comorbidity, and volume confirmed that increased perioperative mortality was associated with
black race for open surgery (OR, 2.0, 95% CI, 1.5-2.5; P< .001) but not TEVAR (OR, 0.9, 95% CI, 0.6-1.5; P .721).
Conclusions: While racial disparities in surgical care have a significant effect on mortality with open thoracoabdominal
aortic aneurysm repair, black patients undergoing TEVAR obtain similar outcomes as white patients. New technology
can limit the effect of racial disparities in surgical care. ( J Vasc Surg 2013;57:56-63.)
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tFor patients undergoing high-risk vascular surgery, a
multitude of reports have established that volume-based
disparities in surgical care are often associated with poorer
results.1-3 Further, volume-outcome disparities often dis-
proportionately affect African American patients, who tend
to seek care at low-volume hospitals.4,5 Examples of these
patterns in vascular care have been well-described in periph-
eral bypass surgery, carotid revascularization, and abdomi-
nal aortic aneurysm surgery.6-8
Implementing policy-based solutions for volume-based
disparities (such as regionalization strategies) has been dif-
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56cult, and largely unsuccessful, for several reasons.9-11
irst, there is often not enough access capacity in high-
olume hospitals to allow all patients to have surgery at
hese centers.12,13 Second, patient preferences in choosing
here to have surgery often considers several other vari-
bles more strongly than volume.9 Finally, cultural barriers
o racial integration have been well documented,14,15 and
herefore changing patterns of care in African American
atients has become particularly difficult.
However, there may be alternative strategies, rather
han simply regionalization, to improve vascular care for
frican American patients who seek care at low-volume
ospitals. Rather than moving these patients to a higher-
olume hospital for open thoracic aortic aneurysm (TAA)
epair, we hypothesized that dissemination of a lower-risk
lternative, such as thoracic endovascular aneurysm repair
TEVAR), would potentially result in lower perioperative
isks at both high- and low-volume centers. Therefore, we
xamined the interaction between new technology and
igh-risk vascular surgery, and race, using repair of thoracic
ortic aneurysm as our study population, given its strong
olume-outcome effect.16,17
ETHODS
Establishing a cohort of Medicare patients who
nderwent repair of TAA. We used the Medicare Physi-
ian/Supplier file and the Medicare Denominator file for
hese analyses, for the years 1998-2007. We selected from
his cohort those patients who underwent TEVAR and
pen repair of TAA, using International Classification of
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Volume 57, Number 1 Goodney et al 57Diseases, Ninth Revision (ICD-9) procedural codes as out-
lined in the Appendix. As outlined in Fig 1, we eliminated
all claims that were not contained in the Medicare Denom-
inator File, as well as patients not at least age 66. We
required patients to have at least 1 year of Medicare eligi-
bility prior to surgery and used this time period to establish
comorbidities and construct patient-specific Charlson
scores.18 The Charlson score contains 19 categories of
comorbidity, based on ICD-9 diagnosis and procedure
codes and has been validated in a variety of settings for use
in administrative datasets.19,20
In addition to the procedural codes for TAA, we re-
quired that each patient have a diagnosis code for TAA.
Initially, we studied five distinct diagnoses, as indicated by
their respective ICD-9 diagnosis codes (Appendix, online
only). We excluded any patient with diagnosis codes for
ascending thoracic aortic aneurysm or with procedural
codes for cardiopulmonary bypass occurring with circula-
tory arrest. Further, we excluded patients with thoracoab-
dominal aneurysms, thoracic aortic dissections, and
“other” aortic pathology from our analysis, as these entities
are clinically distinct from TAAs. Lastly, we also excluded
patients with ICD-9 procedural codes that may indicate the
presence of “debranching” or other procedures to extend
endovascular landing zones, such as 39.24 (aorto-renal
bypass), 39.25 (aorta-iliac-femoral bypass). In situations
wherein we encountered more than one procedure (open
repair or TEVAR) per patient, we assigned the patient to
the first procedure performed.
Exposure variables. Once we established a cohort of
patients with diagnosis codes and procedural codes for
28,480 Patien
Thoracic Ao
15,305 Patients Un
Descending Thorac
722 Black Patients (4.7% of all patients)
626 Intact, 96 Ruptured
516 Open Surgical Repair (71%) 
206 TEVAR (29%)
Fig 1. Derivation of the study cohort. TETAA repair, we categorized patients by procedure type: either open surgical repair or endovascular repair
TEVAR). Then, we stratified patients by our main expo-
ure variables: race and volume. First, race was dichoto-
ized as black or white, which was defined as all white
atients. Next, hospital volume status was defined as total
nnual volume of the procedure at the center where the
atient underwent repair, for each procedure type (open
epair and TEVAR). Volume was assessed both continu-
usly, as well as in five evenly sized groups (quintiles)
rdered by the overall procedure-specific volume rate. After
ur main exposure variables, we defined demographic vari-
bles such as age, sex, and comorbidity score using the
harlson comorbidity index, as outlined above.
Main outcome measures. Our first main outcome
easure was perioperative mortality. To define periopera-
ive mortality, we sought to capture all deaths occurring
n the period following surgery. Therefore, we defined
erioperative mortality as death occurring within the
ndex hospitalization (regardless of postoperative day),
s well as any death within 30 days (irrespective of
npatient or outpatient status). The outcome of periop-
rative death was a binary categorical variable and was
nalyzed using 2 tests.
Our second main outcome measure was survival at 1
nd 5 years, again established using the Medicare denomi-
ator file to establish the date of death. We censored those
atients who survived until the end of our analysis (at
ecember 31, 2007). Survival curves were estimated using
aplan-Meier analysis, and life-table analysis was used to
stablish rates of 5-year survival with surrounding 95% CIs.
og-rank tests were used to determine significant differ-
ergoing 
rgery
Excluded:
5,595 Claims: Thoracoabdominal Diagnosis Codes
7,497 Claims: Dissection Diagnosis Codes
83 Claims: Other aortic pathology Diagnosis Codes      
ing Repair of 
rtic Aneurysm
14,583 White (Non-Black) Patients 
(95.2% of patients)
(97% White, 1.0%  Native American, 0.9% Hispanic, 0.9% 
Asian American, 0.1% Pacific Islander, 0.1 % missing)
13,372 Intact, 1,211 Ruptured
12,057 Open Surgical Repair (83%) 
2,526 TEVAR (17%)  
, Thoracic endovascular aneurysm repair.ts Und
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January 201358 Goodney et alconsidered significant. We categorized survival by race, for
both open surgical repair and TEVAR.
Multivariable analyses to adjust for differences in
patient race, by race and volume strata. To account for
differences in patient characteristics by race, we used mul-
tivariable logistic regression to adjust for differences be-
tween black and white patients. We modeled patient age,
gender, socioeconomic status, and hospital volume against
our main outcome measure. We used backward stepwise
regression and considered all variables with P  .2 for inclu-
sion in the model. Model discrimination was assessed using
the area under the receiver-operator characteristic curve, and
model calibration was assessed using goodness-of-fit tests. All
analyseswere performedusing SAS (SAS Institute,Cary,NC),
and Stata 10 (Stata, College Station, Tex).
RESULTS
Characteristics of the cohort of patients undergo-
ing TAA, by race. Overall, we studied 12,573 Medicare
patients who underwent open procedures and 2732 pa-
tients who underwent TEVAR (Fig 1). Of these, 722
(4.7%) were black, and 14,583 (95.2%) were nonblack. The
majority were of white race, (97% white, 1.0% Native
American, 0.9% Hispanic, 0.9% Asian American, 0.1% Pa-
cific Islander, 0.1% missing), and for clarity, this group is
referred to as “white.” By race, white patients were slightly
older (74.5 vs 73.7 years; P  .001) (Table I). Further,
black patients undergoing TAA repair were more likely to
have diabetes, a history of myocardial infarction or conges-
tive heart failure, and chronic obstructive pulmonary dis-
ease than white patients undergoing TAA repair.
Among patients presenting with intact TAAs, black
patients were more likely to undergo TEVAR compared
with white patients, as 29.3% of black patients underwent
TEVAR, vs 16.8% of white patients with TAAs. In contrast,
white patients were more likely to undergo open surgical
repair compared with black patients. We found that 83.2%
of white patients underwent open surgical repair, while
fewer (70.7% of black patients) underwent open surgical
repair in white patients (P  .001).
Among patients presenting with ruptured TAAs, black
Table I. Patient demographics, by race and repair type
Characteristic
Overall
(n  15,305) 95% CI
Bl
(n 
Age 74.3 (74.2-74.4) 73.
Proportion male 55.8% (55.0-56.6) 43.
Diabetes 4.90% (4.5-5.2%) 11.
Myocardial infarction 5.4% (5.0-5.7%) 7.
Congestive heart failure 10.5% (10.0-11.0%) 19.
Cerebrovascular disease 3.7% (3.4-4.0%) 4.
COPD 12.8% (12.3-13.3%) 19.
Chronic renal failure 1.8% (1.6-2.0%) 3.
History of malignancy 3.4% (3.1-3.7%) 4.
Charlson comorbidity score 0.96 (0.93-0.98) 1.
CI, Confidence interval; COPD, chronic obstructive pulmonary disease.race was more prevalent than in intact repair (7.3% vs 4.4%; T .001). In terms of procedure type, black patients
resenting with ruptured TAAs were just as likely to be
reated with TEVAR as white patients, as 23.0% of both
lack and white patients were treated with endovascular
pproaches when representing with ruptured TAAs.
By volume strata, black patients undergoing open re-
air were most likely to undergo surgery in very low-
olume hospitals (P  .003). Moreover, 29% of all black
atients who underwent open repair had their procedure
erformed in centers in the lowest quintile of hospital
olume, where fewer than five procedures per year were
erformed (Fig 2). However, in TEVAR, black patients
ere more evenly distributed across volume strata. For
xample, 20% of TEVARs performed in black patients were
erformed in the lowest quintile of hospital volume, and
7% of TEVARs were performed in the highest quintile of
ospital volume (P trend by volume strata  .908). In
onblack patients, there were no significant differences in
atient distribution by volume strata, across procedure
ype. For open surgery, 21% of patients underwent surgery
n hospitals in the lowest quintile of hospital volume, and
9% of patients underwent surgery in hospitals in the
ighest quintile of hospital volume (P  .347), and find-
ngs were similar for TEVAR.
Perioperative mortality and survival, by race.
verall, 30-day/in-hospital mortality was slightly lower for
lective TEVAR compared with elective open surgical re-
air, although this difference was not statistically significant
6.1% TEVAR, 7.1% open surgical repair; P .563). When
e examined perioperative mortality by race and procedure
ype, we found that in open surgical repair, black race was
ssociated with significantly higher perioperative mortality
6.8% white, 14.4% black; P .001) (Fig 3). However, for
EVAR, there was no difference in perioperative mortality
cross racial groups (6.0% white, 7.1% black; P  .535).
For patients presenting with rupture, perioperative
ortality was significantly higher with open surgical
epair compared with TEVAR (45% open surgical repair,
8.4% TEVAR; P .001). This effect was similar in both
hite (46.2% open surgical repair, 29.7% TEVAR; P 
001) and black patients (38% open surgical repair, 13%
95% CI
White
(n  14,583) 95% CI
P value
(black vs white)
(72.9-73.7) 74.4 (74.3-74.5) .001
(39.8-47.1) 56.4% (55.6-57.2) .02
(9.2-13.9%) 4.50% (4.2-4.9%) .001
(5.5%-9.4%) 5.30% (4.9-5.6%) .001
(16.2-21.9%) 10.10% (9.6-10.6%) .001
(2.5-5.4%) 3.60% (3.3-4.0%) .492
(16.2-21.9%) 12.50% (11.9-13.0%) .001
(2.4-5.2%) 1.70% (1.5-1.9%) .001
(3.1-6.2%) 3.30% (3.0-3.6%) .001
(1.36-1.67) 0.92 (0.90-0.95) .001ack
722)
4
4%
60%
40%
10%
00%
10%
90%
70%
51EVAR; P  .02).
a
w
h
f
r
h
v
t
i
a
v
h
c
a
m
w
v
v
.
m
l
P
e
s
h
d
m
o
h
P
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 1 Goodney et al 59Next, we compared 5-year survival, by procedure type.
Overall, patients with intact TAAs selected for TEVAR had
poorer 5-year survival than patients undergoing open sur-
gical repair (open surgical repair 5-year survival, 70%; 95%
CI, 66%-72%; and TEVAR 5-year survival, 56%; 95% CI,
52%-60%; log-rank, P  .001) (Fig 3). As with periopera-
tive mortality, 5-year survival in patients undergoing open
surgical repair was worse for black patients compared with
white patients (open surgical repair 5-year survival, 71%;
95% CI, 66%-72%; and TEVAR 5-year survival, 61%; 95%
CI, 55%-66%; log-rank, P  .001). However, in TEVAR,
there were no significant differences in 5-year survival
across race strata (log-rank, P  .563) (Fig 4). These
findings were similar in both aggregate analyses of all TAA
29%
20%
17% 16
0%
10%
20%
30%
Open Surgical R
Annual Volum
p=0.003
1-4     5-8     9-15   16
Proportion of 
All Black
Patients 
Undergoing 
TAA Repair
(%)
Fig 2. Distribution of patients across volume strata for
TEVAR, thoracic endovascular aneurysm repair.
p<0.001
14.4%15%
P i ti
10%
er opera ve
Mortality (%)
p=0.563
7.1%6.8%
6 1%.
5%
0%
White WhiteBlack Black
Open Surgical Repair TEVAR
Fig 3. Perioperative mortality by race and procedure type. TEVAR,
Thoracic endovascular aneurysm repair.repairs, as well as analyses stratified by rupture status. uRace, hospital volume, and mortality. We examined
ssociations between hospital volume and race in terms of
here patients seek care, as well as associations between
ospital volume, race, and perioperative mortality. We
ound that annual hospital volume for open surgical repair
anged fromoneopen surgical repair/year in very low-volume
ospitals, to 46 open surgical repairs/year in very high-
olumehospitals. Thehighest-volumehospital averagedmore
han 145 open surgical repairs annually (for isolated descend-
ng thoracic aneurysm) over the study period. For TEVAR,
nnual hospital volume ranged from one TEVAR per year in
ery low-volume hospitals to 18 TEVAR per year in very
igh-volume hospitals. The highest-volume TEVAR hospital
ompleted more than 25 TEVARs for descending thoracic
neurysms annually in the last 3 years of the study period.
Hospital volume was inversely related to perioperative
ortality for open surgical repair. As shown in Fig 5, there
as a significant difference in perioperative mortality across
olume strata for open surgical repair (13.5% in very low-
olume hospitals, 7.3% in very high-volume hospitals; P 
001). However, there was no difference in perioperative
ortality across volume strata for TEVAR (9.0% in very
ow-volume hospitals, 7.3% in very high-volume hospitals;
 .328).
Multivariable associations between race and periop-
rative mortality. We used multivariable logistic regres-
ion models to examine the interactions between race,
ospital volume (as well as the other demographic and
escriptive variables in our dataset), and perioperative
ortality. As shown in Table II, for patients undergoing
pen surgical repair, black race was associated with
igher operative mortality (OR, 2.0; 95% CI, 1.5-2.5;
 .0001) even when adjusting for age, hospital vol-
20% 20%
21%
22%
%
17%
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p=0.908
Annual Volume
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January 201360 Goodney et algoing TEVAR, while age, sex, and comorbidity continued to
exhibit a significant association with perioperative mortality,
neither black race (OR, 0.9; 95% CI, 0.5-1.6; P .721) nor
hospital volume (OR, 0.8; 95% CI, 0.5-1.2; P .2111) were
associated with a higher risk of perioperative mortality.
DISCUSSION
As with a variety of complex, high-risk surgical proce-
dures, hospital volume is an important determinant of
Fig 4. Overall 5-year survival by procedure type and
endovascular aneurysm repair.outcome following open surgical repair of TAAs.2,17 Fur- sher, as with many prior studies, disparities in hospital
erformance by volume disproportionately affect African
merican patients, who commonly seek care at low-volume
ospitals, and thus, commonly receive worse outcomes in
rocedures with significant volume-outcome relation-
hips.5,7,8,14 However, the dissemination and utilization of
EVAR may offer insight into ways to limit volume-
utcome disparities, especially in African American patients.
ithout any complex, potentially disruptive regionalization
. TAA, Thoracic aortic aneurysm; TEVAR, thoracicracetrategy,21 without any large-scale implementation of health
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Volume 57, Number 1 Goodney et al 61policy,22 and without moving any patient farther from their
family and local support environment,23 vascular care for
African American patients with TAAs has improved, and the
effect of volume-based disparities disappeared.
Disparities in care resultant from volume-outcome re-
lationships have been described in vascular surgery, across a
variety of procedures. Similarly, health policy changes to
address these disparities have varied from limited efforts
aimed at educating patients, to more extensive and conten-
tious policy changes such as reimbursement guidelines
based on volume, certificate of need programs, and selec-
14%
11%
11%
8
0%
10%
Perioperative
Mortality (%)
Annual Volum
1-4     5-8     9-15   1
p=0.001
Fig 5. Mortality by hospital
Table II. Multivariable model association with perioperat
Open surgery model
OR 95% CI
Age
65-70 Referent
71-75 1.4 1.2 1.7
76-80 1.7 1.4 2.0
81-85 2.8 2.3 3.5
85-90 5.1 3.8 6.9
90-95 12.5 4.7 33.1
95 (Omitted)
Male sex 0.9 0.8 1.1
Black race 2.0 1.5 2.5
Hospital volume
Very low volume Referent
Low volume 0.7 0.6 0.9
Medium volume 0.8 0.7 0.9
High volume 0.5 0.5 0.7
Very high volume 0.5 0.4 0.6
Charlson score 3 1.6 1.4 1.8
AUC  0.74
AUC, Area under the curve; CI, confidence interval; OR, odds ratio; TEVAtive referral policies.24 However, many of these policies aave proven unpopular or unsuccessful, as patients are
ften unwilling, because of perceived or actual limitations
n access to care, or unable to seek care at hospitals distant
rom their home, and their families may be unable to
articipate in their care if it is delivered in a distant cen-
er.25,26 Further, other studies suggest that the additional
apacity necessary to perform all high-risk procedures in
igh-volume centers would far exceed the number of avail-
ble surgical beds in the region.13
Racial disparities, which often reflect volume-outcome
isparities, have also been especially apparent in structural
9%
10%
9%
7%% 7%
Annual Volume
46    0-1      2-3    4-8   9-16    >18    
p=0.328
e strata and procedure type.
ortality, by procedure type
TEVAR model
P value OR 95% CI P value
.001 1.0 0.6 1.6 .895
.001 1.6 1.0 2.5 .047
.001 1.5 0.9 2.3 .119
.001 2.4 1.4 4.1 .002
.001 2.3 0.8 6.3 .12
6.5 1.1 37.5 .035
.288 0.8 0.6 1.0 .041
0 0.9 0.5 1.6 .721
Referent
.001 1.1 0.7 1.6 .778
.007 1.0 0.7 1.5 .984
.001 0.7 0.5 1.1 .148
.001 0.8 0.5 1.2 .211
.001 1.4 1.0 1.8 .022
AUC  0.73
oracic endovascular aneurysm repair.%
7
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6-46  >ive mspects of surgical care4,7,8 and, in particular, cardiovascular
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January 201362 Goodney et alcare.27 For example, in a large study of over a million
patients treated with acutemyocardial infarction, Skinner et
al demonstrated that black patients with similar levels of
comorbidities had poorer outcomes when treated at hospi-
tals that primarily treat black patients.28 Further, black
patients have been shown to be less likely to receive endo-
vascular aneurysm for infrarenal abdominal aortic aneu-
rysm, even when controlling for differences in patient char-
acteristics and hospitals where they receive care.6 Finally,
patients in predominantly poor, black regions have a signif-
icantly lower likelihood of undergoing revascularization
prior to amputation for critical limb ischemia.29 Our study,
at least for patients undergoing open surgical repair, adds to
this broad body of evidence describing unfavorable dispar-
ities in care for black patients.
However, our study of patients undergoing TEVAR
demonstrates that well-disseminated technical innovation
was an effective strategy in reducing the gap in racial
disparities. While limited to a single procedure, in this
setting, innovation in surgical technology transformed a
complex open surgical procedure with a significant volume-
outcome effect into a less-complex endovascular procedure
with no volume-outcome effect. Further, TEVAR dissem-
inated widely and rapidly across hospitals – even hospitals
that disproportionally treat black patients.
Several have challenged surgeons and health services
researchers to devise potential solutions, rather than to
continue to simply outline the current state of disparity.8
While inferences from our dataset have obvious limitations,
the model reviewed in our manuscript, wherein creating
reproducible, effective technology that is dispersed across a
variety of settings, has been an effective solution in reduc-
ing racial disparities in TEVAR.
But besides hoping for another “endovascular revolu-
tion,” how can future health policy limit racial disparities?
First, especially in the era of accountable care organizations
and cost containment, surgical investigators and funding
agencies should focus their efforts on designing and imple-
menting new treatments that will be easily generalized across
practice settings and hospitals, so these innovations might
affect a broad spectrum of patients. Second, our study implies
that it is necessary for policymakers to ensure that new tech-
nology is available in both academic centers and community
settings, to allow care to reach diverse and disadvantaged
populations, rather than simply those with access to tertiary
centers.
Our study has several limitations. First, inspection of
our study cohort reveals that we had a relatively small
number of black patients undergoing repair of TAAs. How-
ever, this cohort remains among the largest described for
TAA repair, both overall and among black patients. Sec-
ond, because of the relatively small sample of black patients,
volume-strata-specific comparison of black and white mor-
tality rates was not possible, especially given the small
number of black patients undergoing surgery at high-
volume hospitals. However, this fact, in and of itself, sug-
gests that patients are not distributed evenly among hospi-
tals, a disparity highlighted in our analysis. Third, while WEVAR managed to limit racial disparities for TAA repair,
imilar analyses beyond the scope of this work suggest that
he same findingmay not translate to infrarenal AAA repair.
his may result from the smaller baseline mortality rates for
oth procedures but more notably infrarenal endovascular
neurysm repair. Further, it is important to note that our
tudy suggests that implementation of endovascular pro-
rams can be accomplished in settings that routinely treat
frican American patients. Fourth, our dataset involved the
ime period within which TEVAR “came of age” and began
o be used commonly. While repeating our analyses limited
o only those years wherein TEVAR was used commonly
2005-2007), following Food and Drug Administration
pproval in 2005, resulted in much smaller sample size,
either the magnitude nor the direction of effect of our
ndings changed significantly. And finally, the limitations
n the use of administrative data in adjusting for selection
ias across procedures are well described. While we cannot
e completely certain that patients undergoing open surgi-
al repair and TEVAR were identical anatomically, and our
esults must be considered in the context of administrative
ata, it is important to note that our analysis took several
teps to generate a cohort of patients who could have
eceived either type of repair. As described in our prior
fforts,30,31 we generated our cohort by excluding all pa-
ients with billing or diagnosis codes, indicating extent of
heir TAA such that we excluded any patient inwhom surgical
r endovascular intervention involving the subclavian artery,
he visceral segment, or cardiopulmonary bypasswas required.
he similarity of these groups was evidenced in these analyses,
hen risk-adjusted and propensity-matched analyses gener-
ted similar findings, in terms of both perioperative and long-
erm survival. And fifth, we used a categorization scheme of
lack and white (ie, nonblack) patients in this analysis.
hile health care disparities in Hispanic, Native Ameri-
an, and other ethnic groups have been reported, these
roups constituted fewer than 0.5% of the patients in our
nalysis, and evidence surrounding health disparities (es-
ecially in Hispanic patients) has been difficult to quan-
ify.32
In conclusion, our study suggests that while racial
isparities in surgical care have a significant effect on mor-
ality with open thoracoabdominal aortic aneurysm repair,
lack patients undergoing TEVAR obtain similar outcomes
s white patients. New technology can limit the effect of
acial disparities in cardiovascular care. While regionaliza-
ion and selective referral strategies will undoubtedly con-
inue to evolve, leaders in developing health policy in
urgery should also encourage the development of broadly
pplicable, generalizable solutions to surgical problems af-
ected by racial disparities.
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January 201363.e1 Goodney et alAppendix (online only). ICD-9 diagnosis and procedure codes used to define the cohort
ICD-9 diagnosis codes Open ICD-9 procedure codes TEVAR ICD-9 procedure code
Intact thoracic aneurysms 441.2
38.35, 38.45 39.73, 39.79
Ruptured thoracic aneurysms 441.1, 441.5
Intact thoracoabdominal aneurysms 441.7
Ruptured thoracoabdominal aneurysms 441.6
Thoracic aortic dissection 441.00, 441.01, 441.03
Other thoracic aortic pathology 441.9
ICD-9, International Statistical Classification of Diseases, Ninth Revision; TEVAR, thoracic endovascular aneurysm repair.
